癌診療指針のための病理診断プラクティス　脳腫瘍

出版社： 中山書店
著者：
発行日： 2012-12-14
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784521736747
シリーズ： 癌診療指針のための病理診断プラクティス
電子書籍版： 2012-12-14 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

20,900 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

20,900 円(税込)

購入する

商品紹介

一部の病院を除けば，病理医にとって脳腫瘍の検体に触れることは多くはなく，133種もある脳腫瘍の病理を学習しておくことは難しい。そんな現場の要望に応え，さっと引けてさっと当てはめることができる脳腫瘍病理診断の決定版．疾患別にフローチャートを示し，豊富な病理写真とともに解説する。“絵合わせ診断”にも便利．むしろ普段，脳腫瘍と接する機会の少ない，病理医，外科医にお勧めします。

目次

  • 癌診療指針のための病理診断プラクティス　脳腫瘍

    ―目次―

    1章　病理診断の流れとポイント
    　脳腫瘍の病理診断
    　術中生検診断のポイント

    2章　診断のための基本知識
    　脳腫瘍の臨床的診断
    　　形態画像診断
    　　機能画像診断
    　　脳生検，術中モニタリング・MRI
    　脳腫瘍の治療
    　　外科療法
    　　放射線療法
    　　化学療法
    　　分子標的療法
    　　病理診断と治療

    3章　脳腫瘍の概要と鑑別診断
    　浸潤性星細胞腫
    　限局性星細胞腫
    　乏突起膠細胞系腫瘍
    　上衣性腫瘍
    　脈絡叢腫瘍
    　その他の神経上皮性腫瘍
    　神経細胞系腫瘍
    　松果体部腫瘍
    　胎児性腫瘍
    　脳神経・末梢神経腫瘍
    　髄膜腫
    　間葉系腫瘍
    　血管芽腫，血管周皮腫
    　悪性リンパ腫
    　胚細胞腫瘍
    　トルコ鞍部腫瘍

    4章　病理検体の取り扱い
    　脳腫瘍病理検体の取り扱い

    5章　症例の実際
    　症例1　乏突起膠腫の神経細胞分化
    　症例2　再発を繰り返す粘液乳頭状上衣腫
    　症例3　多彩な免疫表現型を示した小児脳腫瘍
    　症例4　退形成性星芽腫
    　症例5　リンパ腫様肉芽腫瘍
    　症例6　脳原発リンパ腫
    　症例7　髄膜腫への癌転移

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 病理診断の流れとポイント

P.23 掲載の参考文献
Joseph JT. Diagnostic Neuropathology Smears. Lippincott : Williams and Wilkins ; 2007.
 
Burger PC. Smears and Frozen Sections in Surgical Neuropathology. Baltimore : PB Medical Publishing ; 2009.
 
Prayson RA, Napekoski KM. Frozen Section Library : Central Nervous System. New York ; Springer ; 2011.
 
Welsh CT. Intraoperative Neuropathology for the Non-neuropathologist. A case-based approach. New York : Springer ; 2012.
 

2章 診断のための基本知識

P.28 掲載の参考文献
青木茂樹. 神経放射線学的検査. MRIの撮像法. 水野義邦編. 神経内科ハンドブック. 第4版 . 東京 : 医学書院 ; 2010. p.409.
 
青木茂樹. 検査・読影法と正常解剖. 青木茂樹編著. 新版よくわかる脳MRI. 第2版 . 東京 : 秀順社 ; 2004. p.16 -25.
 
青木茂樹編著. 所見からせまる脳MRI. 第2版 . 東京 : 秀順社 ; 2004.
 
P.41 掲載の参考文献
河井信行ほか. 脳腫瘍におけるメチオニンPET. 脳神経外科. 2008 : 36 ; 847-59.
 
田宮隆ほか. 脳腫瘍の画像診断 Methionine PETによる神経膠腫の鑑別診断. 新時代の脳腫瘍学. 日本臨牀増刊. 2010 : 279-83.
 
Shinozaki N, et al. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. J Neurosurg. 2011 : 114 (6) ; 1640-7.
PubMed
奥山智緒. SPECTによる脳腫瘍の診断. 最新 脳SPECT/PETの臨床. 東京 : メジカルビュー社 ; 2002. p.96-101.
 
木村浩彦. 脳腫瘍の画像診断 MRS MR spectroscopy. 新時代の脳腫瘍学. 日本臨牀増刊. 2010 : 249-52.
 
今西好正ほか. こころから納得・理解できるMRI原理とMRS. 東京 : 医療科学社 ; 2009. 186-212.
 
P.46 掲載の参考文献
Woodworth G, et al. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma : comparison of biopsy and open resection specimen. Neurol Res. 2005 ; 27 : 358-62.
PubMed
Muragaki Y, et al. Low-grade glioma on stereotactic biopsy : how often is the diagnosis accurate? Minim Invasive Neurosurg. 2008 ; 51 : 275-9.
PubMed
Chernov MF, et al. Spectroscopy-supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions : comparative evaluation of diagnostic yield and diagnostic accuracy. Clin Neurol Neurosurg. 2009 ; 111 : 527-35.
PubMed
Kamada K, et al. The motor-evoked potential threshold evaluated by tractography and electrical stimulation. J Neurosurg. 2009 ; 111 : 785-95.
PubMed
Maesawa S, et al. Intraoperative tractography and motor evoked potential (MEP) monitoring in surgery for gliomas around the corticospinal tract. World Neurosurg. 2010 ; 74 : 153-61.
 
櫻田香ほか. 術中MRIにて急性硬膜下血腫を診断し得た悪性神経膠腫の一例. 脳神経外科. 2010 ; 38 : 1115-20.
 
Moriuchi S, et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. J Neurosurg. 2011 ; 115 : 278-80.
 
Kayama T. The guidelines for awake craniotomy. guidelines committee of the Japan awake surgery conference. Neurol MedChir. 2012 ; 52 : 119-41.
 
P.52 掲載の参考文献
Lacroix M, et al. A multivariate analysis of 416 patients with glioblastoma multiforme : prognosis, extent of resection, and survival. J Neurosurg. 2001 ; 95 : 190-8.
 
Sanai N, et al. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011 ; 115 : 3-8.
PubMed
Smith JS, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008 ; 26 : 1338-45.
 
Sawamura Y, et al. Management of primary intracranial germinomas : diagnostic surgery or radical resection? J Neurosurg. 1997 ; 87 : 262-6.
PubMed
Shibamoto Y, et al. Reduction of the radiation dose for intracranial germinoma : a prospective study. Br J Cancer. 1994 ; 70 : 984-9.
PubMed
Ushio Y, et al. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma : report of five cases. J Neurosurg. 1999 ; 90 : 133-7.
PubMed
Ferreri AJ. How I treat primary CNS lymphoma. Blood. 2011 ; 118 : 510-22.
 
Bellinzona M, et al. Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions : a series of 33 cases. Eur J Surg Oncol. 2005 ; 31 : 100-5.
PubMed
Reni M, et al. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients : results of a critical review of the literature. Ann Oncol. 1997 ; 8 : 227-34.
PubMed
Sacko O, et al. Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery. 2011 ; 68 : 1192-8 ; discussion 1198-9.
 
Sanai N, et al. Functional outcome after language mapping for glioma resection. N Engl J Med. 2008 ; 358 : 18-27.
PubMed
Duffau H, et al. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere. J Neurosurg. 2008 ; 109 : 461-71.
 
P.64 掲載の参考文献
Hall EJ, Giaccia AJ. Radiobiology for the Radiobiologist. 7th ed. Philadelphia : Lippincott Williams & Wilkins ; 2012.
 
青山喬, 丹羽太貫. 放射線基礎医学. 第11版. 京都 : 金芳堂 ; 2008.
 
Halperin EC, et al. Principle and Practice of Radiation Oncology. 5th ed. Philadelphia : Lippincott Williams & Wilkins ; 2008.
 
大西洋ほか. 癌・放射線療法 2010. 東京 : 篠原出版新社 ; 2010.
 
NCCN Clinical Practice Guidelines in Oncology : Central nervous system cancers Version 1. 2012. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
 
日本放射線科専門医会・医会ほか. 放射線治療計画ガイドライン 2008. 埼玉 : メディカル教育研究社 ; 2008.
 
Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 ; 352 : 987-96.
PubMed
Amelio D, et al. Intensity-modulated radiation therapy in newly diagnosed glioblastoma : a systematic review on clinical and technical issues. Radiother Oncol. 2010 ; 97 : 361-9.
PubMed
Packer RJ, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006 ; 24 : 4202-8.
PubMed
Gavrilovic IT, et al. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006 ; 24 : 4570-4.
PubMed
P.75 掲載の参考文献
Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009 ; 10 : 459-66.
 
Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 ; 352 : 987-96.
PubMed
Hegi ME, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 ; 352 : 997-1003.
PubMed
Friedman HS, et al. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res. 1997 ; 57 : 2933-6.
 
Felsberg J, et al. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer. 2011 ; 129 : 659-70.
PubMed
Friedman HS, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 ; 27 : 4733-40.
PubMed
Kreisl TN, et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol. 2009 ; 27 : 740-5.
PubMed
Taylor MD, et al. Molecular subgroups of medulloblastoma : the current consensus. Acta Neuropathol 2012 ; 123 : 465-72.
PubMed
Packer RJ, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006 ; 24 : 4202-8.
PubMed
Hiraga S, et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg. 1999 ; 91 : 221-30.
PubMed
O'Brien PC, et al. Combined-modality therapy for primary central nervous system lymphoma : long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys. 2006 ; 64 : 408-13.
PubMed
Ferreri AJ, et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma : a randomised phase 2 trial. Lancet. 2009 ; 374 : 1512-20.
PubMed
西川亮. 中枢神経胚細胞腫瘍治療の基本方針. Jpn J Neurosurg (Tokyo). 2006 ; 15 : 171-6.
 
P.86 掲載の参考文献
Reardon DA, et al. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol. 2005 ; 23 : 9359-68.
PubMed
Fine HA L, et al. Thornton results from Phase II trial of enzastaurin (LY317615) in patients with recurrent high grade gliomas. 2005 ASCO Annual Meeting Proceedings. J Clin Oncol. 2005 ; 23 (S16) (1 Suppl.) : 1504 .
 
Vredenburgh JJ, et al. Phase II trial of bevacizumab and irinotecan in recurrentmalignant glioma. Clin Cancer Res. 2007 ; 13 : 1253-9.
PubMed
Mellinghoff IK, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med. 2005 ; 353 : 2012-24.
PubMed
Galanis E, et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme : a North central cancer treatment group study. J Clin Oncol. 2005 ; 23 : 5294-304.
 
Phillips H, et al. Intense focal expression of vascular endothelial growth-factor messenger-RNA in human intracranial neoplasms - association with regions of necrosis. Int J Oncol. 1993 Jun ; 2 (6) : 913-9.
PubMed
Friedman HS, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 ; 27 : 4733-40.
PubMed
Lai A, et al. Phase II trial of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2009 (suppl ; abstr 2000) ; 27 : 15s.
 
Iwamoto FM, et al. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology. 2009 ; 73 : 1200-6.
PubMed
Reardon DA, et al. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol. 2008 ; 26 (34) : 5610-7. Epub 2008 Nov 3.
 
P.91 掲載の参考文献
Kleihues P, et al. WHO grading of tumours of the central nervous system. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.10-1.
 
Wen PY, Kesari S. Malignant gliomas in adults. New Eng J Med. 2008 ; 359 : 492-507.
PubMed
Horbinski C, et al. Brain Pathol. 2011 ; 21 : 564-74.
PubMed
Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas : a review. Neurosurgery. 2005 ; 5 : 538-50.
 

3章 脳腫瘍の概要と鑑別診断

P.102 掲載の参考文献
日本脳神経外科学会, 日本病理学会編. 臨床・病理 脳腫瘍取扱い規約 臨床と病理カラーアトラス. 第3版. 東京 : 金原出版 ; 2010.
 
Burger PC, Scheithauer BW. Tumors of the Central Nervous System. AFIP Atlas of Tumor Pathology, 4th series, fascicle 7. Washington DC : American Registry of Pathology ; 2007.
 
Giannini C, et al. Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol. 1999 ; 58 : 46-53.
PubMed
Hegi ME, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 ; 352 : 997-1003.
PubMed
Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System, 4th ed. Lyon : International Agency for Research on Cancer ; 2007.
 
Ohgaki H, Kleihues P. Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol. 2011 ; 28 : 177-83.
PubMed
Perry A, et al. Malignant gliomas with primitive neuroectodermal tumor-like components : a clinicopathologic and genetic study of 53 cases. Brain Pathol. 2009 ; 19 : 81-90.
 
Perry A, Brat DJ, eds. Practical Surgical Neuropathology. A Diagnostic Approach. Philadelphia : Churchill Livingstone Elsevier ; 2010.
 
Teo JG, et al. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands : report of 4 cases. Am J Surg Pathol. 1999 ; 23 : 502-10.
PubMed
Yan H, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009 ; 360 : 765-73.
PubMed
P.119 掲載の参考文献
Burger PC, Scheithauer BW. Tumors of the Central Nervous System. In : Silverberg SG, Sobin LH, eds. AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 7. Washington DC : American Registry of Patghology and Armed Forces Institute of Pathology ; 2007.
 
Burger PC. Smears and Frozen Sections in Surgical Neuropathology. Baltimore : PB Medical Publishing ; 2009.
 
Louis DN, et al. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007.
PubMed
Perry A, Prayson RA. Glial and glioneuronal tumors. In : Prayson RA, ed. Neuropathology. Philadelphia : Elsevier ; 2012. p.468-79.
 
Tihan T, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neurpopathol Exp Neurol. 1999 ; 58 : 1061-8.
 
岡本浩一郎. 毛様細胞性星細胞腫. 多形黄色星細胞腫. 土屋一洋ほか編. 頭部画像診断のここが鑑別ポイント. 東京 : 羊土社 ; 2005. p.60-3.
 
日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009.
 
日本脳神経外科学会, 日本病理学会編. 臨床・病理 脳腫瘍取扱い規約 臨床と病理カラーアトラス. 第3版. 東京 : 金原出版 ; 2010.
 
P.131 掲載の参考文献
Reifenberger G, et al. Oligodendroglial tumours. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC : 2007. p.53-67.
 
乏突起膠細胞系腫瘍. 日本脳神経外科学会, 日本病理学会編. 脳腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2010. p.102-5.
 
Giannini C, et al. Oligodendrogliomas : reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol. 2001 ; 60 : 248-62.
PubMed
Yokoo H, et al. Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol. 2004 ; 164 : 1717-25.
PubMed
Ducray F, et al. α internexin expression identifies 1p19q codeleted gliomas. Neurology. 2009 ; 72 : 156-61.
 
横尾英明ほか. 明細胞性腫瘍. 病理と臨床. 2010 ; 28 臨時増刊号 : 420-1.
 
P.143 掲載の参考文献
Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon : IARC ; 2007.
 
Burger PC, Scheithauer BW. Tumors of the Central Nervous System. AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 7. Washington DC : Armed Forces Institute of Pathology ; 2007.
 
McLendon RE, et al. Russell & Rubinstein's Pathology of Tumors of the Nervous System. 7th ed. London : Hodder Arnold ; 2006.
 
Burger PC, et al. Surgical Pathology of the Nervous System and Its Coverings. 4th ed. New York : Churchill Livingstone ; 2002.
 
Kawano N, et al. Pathologic features of ependymoma. Histologic patterns and a review of the literature. Neuropathology. 1998 ; 18 : 1-12.
 
Kawano N, et al. Clear cell ependymoma. A histological variant with diagnostic implications. Virchows Archiv A Pathol Anat. 1989 ; 415 : 467-72.
PubMed
Friede RL, Pollak A. The cytogenetic basis of classifying ependymomas. J Neuropathol Exp Neurol. 1978 ; 37 : 103-18.
PubMed
Ho DM, et al. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neuro-oncol. 2001 ; 54 : 77-85.
 
Prayson RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol. 1999 ; 3 : 11-8.
PubMed
Sonneland PRL, et al. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985 ; 56 : 883-93.
 
P.152 掲載の参考文献
Paulus W, Brandner S. Choroid plexus tumours. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p. 82-5.
 
Choroid plexus papilloma, atypical papilloma, and carcinoma. In : Burger PC, Scheithauer BW, eds. Tumors of the Central Nervous System. Washington DC : AFIP ; 2007. p.177-87.
 
安倍雅人. Chroid plexus tumors. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p. 58-9.
 
Ikota H, et al. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors : their histological diversity and the expression of markers useful for differentiation from metastatic cancer. Brain Tumor Pathol. 2011 ; 28 : 215-21.
PubMed
Jeibmann A, et al. Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol. 2006 ; 65 : 1069-73.
PubMed
Wrede B, et al. Atypical choroid plexus papilloma : clinical experience in the CPTSIOP-2000 study. J Neurooncol. 2009 ; 95 : 383-92.
 
Wolff JE, et al. Choroid plexus tumours. Br J Cancer. 2002 ; 87 : 1086-91.
PubMed
Wasita B, et al. Choroid plexus metastasis from papillary thyroid carcinoma presenting with intraventricular hemorrhage : case report. Neurosurgery. 2010 ; 66 : E1213-4.
PubMed
P.159 掲載の参考文献
Aldape KD, et al. Astroblastoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC : 2007. p.88-9.
 
竹島秀雄. Astroblastoma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 : 2009. p.60-1.
 
Burger PC, et al. Angiocentric glioma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC : 2007. p.92-3.
 
柴原純二. Angiocentric glioma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 : 2009. p.64-5.
 
Brat DJ, et al. Chordoid glioma of the third ventricle. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC : 2007. p.90-1.
 
笹嶋寿郎. Chordoid glioma of the third ventricle. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 : 2009. p.62-3.
 
P.169 掲載の参考文献
Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon : IARC ; 2007.
 
日本脳神経外科学会, 日本病理学会編. 臨床・病理脳腫瘍取扱い規約臨床と病理カラーアトラス. 第3版. 東京 : 金原出版 ; 2010.
 
河本圭司ほか編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009.
 
Miller DC, et al. Synaptophysin : a sensitive and specific marker for ganglion cells in central nervous system neoplasms. Hum Pathol. 1990 ; 21 : 93-8.
PubMed
Hirose T, et al. Ganglioglioma. An ultrastructural and immunohistochemical study. Cancer. 1997 ; 79 : 989-1003.
PubMed
Taratuto AL, et al. Superficial cerebral astrocytoma attached to dura. Report of six cases in infants. Cancer. 1990 ; 66 : 173-9.
 
VandenBerg SR, et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg. 1987 ; 66 : 58-71.
PubMed
Komori T, et al. Mixed conventional and desmoplastic infantile ganglioglioma : an autopsied case with 6-year follow-up. Mod Pathol. 2001 ; 14 : 720-6.
PubMed
Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor : a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery. 1988 ; 23 : 545-56.
PubMed
Hassoun J, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol. 1982 ; 56 : 151-6.
PubMed
Giangaspero F, et al. Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol. 1997 ; 21 : 206-12.
PubMed
Rodriguez FJ, et al. Interphase cytogenetics for 1p19q and t (1 ; 19) (q10 ; p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol. 2009 ; 19 : 623-9.
 
Komori T, et al. Papillary glioneuronal tumor : a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol. 1998 ; 22 : 1171-83.
PubMed
Myung JK, et al. Papillary glioneuronal tumors : a review of clinicopathologic and molecular genetic studies. Am J Surg Pathol. 2011 ; 35 : 1794-805.
PubMed
Solis OE, et al. Rosette-forming glioneuronal tumor : a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. J Neurooncol. 2011 ; 102 : 477-84.
 
Komori T, et al. A rosette-forming glioneuronal tumor of the fourth ventricle : infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol. 2002 ; 26 : 582-91.
 
P.186 掲載の参考文献
Nakazato Y, et al. Pineocytoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.122-3.
 
Nakazato Y, et al. Pineal parenchymal tumour of intermediate differentiation. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.124-5.
 
Nakazato Y, et al. Pineoblastoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.126-7.
 
中里洋一. Pineocytoma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.80-1.
 
中里洋一. Pineal parenchymal tumor of intermediate differentiation. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.82-3.
 
中里洋一. Pineoblastoma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.84.
 
Jouvet A, et al. Pineal parenchymal tumors : a correlation of histological features with prognosis in 66 cases. Brain Pathol. 2000 ; 10 : 49-60.
PubMed
Fauchon F, et al. Parenchymal pineal tumors : a clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys. 2000 ; 46 : 959-68.
PubMed
Jouvet A, et al. Papillary tumor of the pineal region. Am J Surg Pathol. 2003 ; 27 : 505-12.
PubMed
Fevre-Montange M, et al. Prognosis and histopathologic features in papillary tumors of the pineal region : a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol. 2006 ; 65 : 1004-11.
 
Jouvet A, et al. Papillary tumour of the pineal region. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.128-9.
 
P.198 掲載の参考文献
Giangaspero F, et al. Medulloblastoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.132-40.
 
McLendon RE, et al. eds. Central nervous system primitive neuroectodermal tumours. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.141-6.
 
Judkins AR, et al. Atypical teratoid/rhabdoid tumour. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.147-9.
 
Report of brain tumor registry of Japan (1984-2000). 12th ed. Neurol med-chir. 2009 ; 49 : Suppl.
 
Partap S, et al. Embryonal Tumor. In : Gupta N, et al, eds. Pediatric CNS Tumors. Heidelberg : Springer ; 2004. p. 89-114.
 
Adesina AM, et al. Central nervous system primitive neuroectodermal tumors and medulloepithelioma. In : Adesina AM, et al. eds. Atlas of Pediatric Brain Tumors. New York : Springer ; 2010. p.63-73.
 
Adesina AM, Hunter J. Medulloblastoma. In : Adesina AM, et al. eds. Atlas of Pediatric Brain Tumors. New York : Springer ; 2010. p.75-93.
 
Eberhart CG, et al. Histopathological grading of medulloblastomas. Cancer. 2002 ; 94 : 552-60.
PubMed
Gessi M, et al. Embryonal tumors with abundant neuropil and true rosettes. Am J Surg Pathol. 2009 ; 33 : 211-7.
PubMed
P.215 掲載の参考文献
Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.152-62.
 
日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.98-104.
 
P.226 掲載の参考文献
中州敏ほか. Meningioma. 河本圭司ほか編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.105-19.
 
The committee of brain tumor registry of Japan. Report of brain tumor registry of Japan (1984-2000). Neurol med chir. 2009 ; 49 (suppl) : 5-38.
 
Perry A, et al. Meningiomas. In : David N L, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.164-72.
 
Simpson D. The recurrence of intracranial meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurg. 1957 ; 20 : 22-39.
 
有田憲生ほか. 髄膜腫. 日本臨牀68巻増刊号10. 新時代の脳腫瘍学. 2010 ; 156-8.
 
P.239 掲載の参考文献
安倍雅人. Solitary fibrous tumor. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.125.
 
Guillou L, et al. Extrapleural solitary fibrous tumour and haemangiopericytoma. In : Fletcher CDM, et al. eds. WHO Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon : IARC ; 2002. p.86-7.
 
長谷川匡. 血管周皮腫様血管構造を伴う軟部腫瘍の鑑別診断. 病理と臨床. 2012 ; 30 : 186-9.
Medical*Online
船田信顕. 髄膜腫. 病理と臨床. 2004 ; 22 : 1028-9.
 
Mirra JM, et al. Chordoma. In : Fletcher CDM, et al. eds. WHO Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon : IARC ; 2002. p.316-7.
 
石田剛. 脊索腫. 骨腫瘍の病理. 東京 : 文光堂 ; 2012. p.311-21.
 
石田剛. 軟骨肉腫. 骨腫瘍の病理. 東京 : 文光堂 ; 2012. p.178-9.
 
本間琢, 佐々木惇. 脳腫瘍の新たな免疫組織化学的マーカー. 病理と臨床. 2012 ; 30 : 395.
 
Brat DJ, Perry A. Melanocytic lesions. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.181-3.
 
日本脳神経外科学会, 日本病理学会編. 臨床・病理 脳腫瘍取扱い規約 臨床と病理カラーアトラス. 第3版. 東京 : 金原出版 ; 2010. p.149-51.
 
柿田明美. Melanocytic tumors. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第3版. 東京 : 医学書院 ; 2009. p.134-6.
 
佐藤一史. 原発性頭蓋内悪性黒色腫. 久保田紀彦, 佐藤一史編. 脳神経外科アドバンス. 東京 : 診断と治療社 ; 2008. p.132-3.
 
P.249 掲載の参考文献
Aldape KD, et al. Haemangioblastoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.184-6.
 
Palte KH, et al. Von Hippel-Lindau disease and haemangioblastoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.215-7.
 
Carney EM, et al. PAX2 (-) /PAX8 (-) /inhibin A (+) immunoprofile in hemangioblastoma : A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol. 2011 ; 35 : 262-7.
 
Hemangioblastoma. In : Burger PC, et al. eds. AFIP Atlas of Tumor Pathology. Tumors of the Central Nervous System, Fascicle 7. Washington : American Registry of Pathology ; 2007. p.309-18.
 
Ma D, et al. Hemangioblastomas might derive from neoplastic transformation of neural stem cells/progenitors in the specific niche. Carcinogenesis. 2011 ; 32 : 102-9.
PubMed
Rivera AL, et al. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma. Neuropathology. 2010 ; 30 : 580-5.
PubMed
Takei H, et al. New immunohistochemical markers in the evaluation of central nervous system tumors : a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med. 2007 ; 131 : 234-41.
PubMed
Giannini C, et al. Haemangiopericytoma. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.178-80.
 
Paulus W, et al. Mesenchymal, non-meningothelial tumours. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.173-7.
 
Hemangiopericytoma. In : Burger PC, eds. AFIP Atlas of Tumor Pathology. Tumors of the Central Nervous System, Fascicle 7. Washington : American Registry of Pathology ; 2007. p.373-8.
 
Schiariti M, et al. Hemangiopericytoma : long-term outcome revisited. J Neurosurg. 2011 ; 114 : 747-55.
PubMed
Chen H, et al. Solitary fibrous tumor of the central nervous system : a clinicopathologic study of 24 cases. Acta Neurochir (Wien). 2012 ; 154 : 237-48.
PubMed
中里洋一. 改訂された脳腫瘍WHO分類. Brain and Nerve. 2008 ; 60 : 59-77.
 
P.259 掲載の参考文献
Swerdlow SH, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon : IARC ; 2008.
 
Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon : IARC ; 2007.
 
Shimada K, et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008 ; 26 : 3189-95.
 
飛内賢正ほか編. 悪性リンパ腫治療マニュアル. 改訂第3版. 東京 : 南江堂 ; 2009.
 
Baraniskin A, et al. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system. Br J Haematol. in press.
 
日本脳神経外科学会ほか編. 臨床・病理 脳腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2010.
 
P.266 掲載の参考文献
Rosenblum MK, et al. Germ cell tumours. In : Louis DN, et al. eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.198-204.
 
Goodwin TL, et al. Incidence patterns of central nervous system germ cell tumors : a SEER study. J Pediatr Hematol Oncol. 2009 ; 31 : 541-4.
PubMed
Leroy X, et al. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem. 2002 ; 50 : 283-5.
PubMed
Santagata S, et al. Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG. Am J Surg Pathol. 2006 ; 30 : 1613-8.
PubMed
Nomura K. Epidemiology of germ cell tumors in Asia of pineal region tumor. J Neurooncol. 2001 ; 54 : 211-7.
PubMed
Matsutani M, et al. Primary intracranial germ cell tumors : a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997 ; 86 : 446-55.
 
Kyritsis AP. Management of primary intracranial germ cell tumors. J Neurooncol. 2010 ; 96 : 143-9.
PubMed
Ushio Y, et al. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg. 1999 ; 90 : 133-7.
PubMed
Lee D, Suh YL. Histologically confirmed intracranial germ cell tumors ; an analysis of 62 patients in a single institute. Virchows Arch. 2010 ; 457 : 347-57.
 
Sawamura Y, et al. Germ cell tumours of the central nervous system : treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer. 1998 ; 34 : 104-10.
PubMed
Kamoshima Y, Sawamura Y. Update on current standard treatments in central nervous system germ cell tumors. Current Opinion in Neurology. 2010 ; 23 : 571-5.
PubMed
Matsutani M, et al. Primary intracranial germ cell tumors : a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997 ; 86 : 446-55.
 
Ogawa K, et al. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors a multiinstitutional retrospective analysis of 41 patients. Cancer. 2003 ; 98 : 369-76.
PubMed
P.279 掲載の参考文献
Sylvia LA. Tumor of the Pituitary Gland. AFIP Atlas of Tumor Pathology, 4th series. Washington DC : American Registry Pathology ; 2011.
 

4章 病理検体の取り扱い

P.292 掲載の参考文献
Somerset HL, Kleinschmidt-DeMaster BK. Approach to the intraoperative consultation for neurolosurgical specimens. Adv Anat Pathol. 2011 ; 18 : 446-9.
 
Powell SZ. Intraoperative consultation, cytologic preparations, and frozen section in the central nervous system. Arch Pathol Lab Med. 2005 ; 129 : 1635-52.
PubMed
Moss TH, et al. Intra-operative Diagnosis of CNS Tumours. London : Arnold ; 1997. p.1-9.
 
平戸純子. 第2部各論 15. 中枢神経系. 深山正久ほか編. 外科病理マニュアル. 病理と臨床. 臨時増刊号. 2008 ; 126 : 217-21.
 
水平敏知編著. 医学・生物学領域の電子顕微鏡操作マニュアル (第3刷). 東京 : 講談社サイエンティフィック ; 1989.
 
Ghadially FN. Diagnostic Electron Microscopy of Tumours, 2nd ed. London : Butterworth ; 1985.
 
McDowell EM, Trump BF. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med. 1976 ; 100 : 405-14.
PubMed
Joseph JT. Diagnostic Neuropathology Smears. Philadelphia : Lippincott Williams & Wilkins ; 2007. p.1-11.
 
Lester SC. Neuropathology Specimens. In : Lester SC, ed. Manual of Surgical Pathology, 3rd ed. Philadelphia : Elsevier Saunders ; 2010. p.527-31.
 

5章 症例の実際

P.302 掲載の参考文献
Tanaka Y, et al. Anaplastic oligodendroglioma with ganglioglioma-like maturation. Brain Tumor Pathol. 2012 ; 11. [Epub ahead of print]
 
Perry A, et al. Oligodendroglial neoplasms with ganglioglioma-like maturation : a diagnostic pitfall. Acta Neuropathol. 2010 ; 120 : 237-52.
PubMed
Capper D, et al. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol. 2011 ; 121 : 241-52.
PubMed
Horbinski C, et al. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathol. 2011 ; 21 : 564-74.
PubMed
P.306 掲載の参考文献
Kurtkaya-Yapicier O, et al. Unusual case of extradural choroid plexus papilloma of the sacral canal. Case report. J Neurosurg. 2002 ; 97 : 102-5.
PubMed
Burger PC, Scheithauer BW. AFIP Atlas of Tumor Pathology, 4th series, Fascicle 7, Tumors of the Central Nervous System. Washington DC : Armed Forces Institute of Pathology ; 2007. p.162.
 
P.315 掲載の参考文献
Port JD, et al. Astroblastoma : radiologic-pathologic correlation and distinction from ependymoma. Am J Neuroradiol. 2002 ; 23 : 243-7.
PubMed
Burger PC, et al, Astroblastoma. In : Burger PC, et al. eds. Surgical Pathology of the Neruvous System and Its Coverings. 4th ed. New York : Churchill Livingstone ; 2002. p.254-6.
 
Aldape KD, Rosenblum MK. Astroblastoma. In : Louis DN, et al, eds. WHO Classification of Tumours of the Central Nervous System. Lyon : IARC ; 2007. p.88-9.
 
日本脳神経外科学会, 日本病理学会編. 臨床・病理 脳腫瘍取扱い規約 臨床と病理カラーアトラス. 第3版. 東京 : 金原出版 ; 2010. p.111-2.
 
Brat DJ, et al. Astroblastoma : clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol. 2000 ; 10 : 342-52.
PubMed
P.320 掲載の参考文献
Liebow AA. Lymphomatoid granulomatosis. Calif Med. 1972 ; 116 : 48-9.
PubMed
Steven HS, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer, 2008.
 
Christoph Wyen, et al. Fatal cerebral lymphomatoid ganulomatosis in an HIV-1 infected patient. Journal of Infection. 2007 ; 54 : e175-8.
 
Arie PMD, et al. Practical Surgical Neuropathology : A Diagnostic Approach. Philadelphia : Churchill Livingstone ; 2010.
 
P.327 掲載の参考文献
Caroli E, et al. Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma. Neurosurg Rev. 2006 ; 29 : 49-54.
PubMed

書評

最近チェックした商品履歴

Loading...